JESSICA PERINI: Open Payments
NPI 1760954572 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 21 payments from 10 companies in 2025. Trend: 2023 $238 · 2024 $180 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $81 |
| GENZYME CORPORATION | 3 | $79 |
| ABBVIE INC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 4 | $40 |
| Novo Nordisk Inc | 2 | $33 |
| Amgen Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $13 |
Products named: TREMFYA, DUPIXENT, JARDIANCE, VOQUEZNA, VRAYLAR, KRYSTEXXA, XIFAXAN, Wegovy.
Industry payments across TX — which companies pay providers there.
